| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.098 | 0.06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.07 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.07 |